You are invited to the 4^th Annual Gyrolab Seminar - a unique opportunity to learn how Gyrolab^® is increasing immunoassay performance and productivity. It promises to be an enjoyable and informative event including an exceptional line-up of expert users presenting key case studies on their implementation of the Gyrolab platform.

York Bioanalytical Solutions: Anne Bourne, Scientist
"Transfer of an Immunoassay from an ELISA method for Human Plasma to Dried Blood Spot Analysis using Gyrolab"

Novartis Vaccines and Diagnostics: Francesca Buricchi, Scientist
"Using Gyrolab to adress memory B cell immune response after vaccination"

ICON: John Chappell, Director of Immunoassay Services UK
"Analytical Support of Monoclonal Antibodies in Clinical and Preclinical Studies"

AstraZeneca: Pia Davidsson, Principal Scientist
"Preclinical PK analysis of antibodies and proteins using Gyrolab"

MedImmune: Jo Goodman, Scientist II
"Development of a Clinical PK Assay using Gyrolab workstation"

BioAnalab (Millipore): Geoff Hale, Managing Director
"Prevention of unwanted immunogenicity by induction of tolerance: pharmacokinetic and anti-drug antibody assays"

Quotient Bioresearch: Chris Jones, Scientist
"Paralell PK and immunogenicity analysis of a monoclonal antibody on Gyrolab"

Ablynx: Gertie de Neve, Senior Research Associate
"Development and validation of a biomarker assay to measure free antigen levels in cynomolgus monkey plasma"

Quotient Bioresearch: Andrew Roberts, Sector Manager
"Development of a Gyrolab method for the quantification of ALX-0081, an antithrombotic Nanobody®, in guinea pig plasma."

AstraZeneca: Zulma Santisteban-Valencia,Senior Research Scientist
"Combination of multi-sampling and Gyrolab offers one full PK in one mouse"

BioGenes: Kathrin Günther, Director International Marketing
"Challenges of HCP assay development: How to meet manufacturers' requirements"

Probiogen: Hans Henning von Horsten, Project & Technology Manager
"High Accuracy Quantification of Therapeutic Proteins in Pharmaceutical Cell Line Development using Gyrolab"

Recipharm Biologics: Anders Hagman, Analytical team manager
"Biopharmaceutical development at Recipharm Biologics"

Merck: Jeanette Roman, Research Biochemist
"Pharmacokinetic Immunoassays using GYROS Microfluidic Technology"

AstraZeneca: Anette Mörtberg, Associate Principal Scientist
"Rat Tau analysis on Gyrolab Workstation: Performance over 2 years"

Radix Biosolutions: Chad A. Ray, Director of Assay Development
"Development and Qualification of a Method to Measure Human IgG using the Gyrolab Platform"

The 4^th Annual Gyrolab Seminars is for anyone involved in the development of protein therapeutics. It is an open-forum to present, discuss and evaluate how Gyrolab contributes to accelerate the development of protein therapeutics. Decision-makers such as researchers, outsourcing officers, CRO/CMO business developers and managers who all share a need to perfect the immunoassay part of their operation will find value in attending.

Order your registration package at the bottom of this page. If you have already logged into your Gyros web account, the form will be automatically filled in for you. The registration package contains the complete invitation and registration forms with event prices specified.

View video highlights of presentations and interviews from the 3^rd Annual Gyrolab Seminar in 2009, where over 50 industry delegates from pharma, biotech, CRO and CMO organizations in Europe and the US came together to discuss how Gyrolab technology has accelerated the development of therapeutic proteins.

The 4^th Annual Gyrolab Seminar will be held at Johannesberg's Castle near Uppsala in Sweden.